These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 3070294)

  • 1. Comparisons between in vivo and in vitro systems: the in vivo equivalent dose concept.
    Paolini M; Cantelli Forti G; Bauer C
    Mutagenesis; 1988 Nov; 3(6):527-31. PubMed ID: 3070294
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro metabolic activation in genotoxicity assays with mammalian cell cultures.
    Belvedere G
    Boll Chim Farm; 1985 Feb; 124(2):57-68. PubMed ID: 4015867
    [No Abstract]   [Full Text] [Related]  

  • 3. Instant and brewed coffees in the in vitro human lymphocyte mutagenicity test.
    Aeschbacher HU; Ruch E; Meier H; Würzner HP; Munoz-Box R
    Food Chem Toxicol; 1985 Aug; 23(8):747-52. PubMed ID: 4043880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Qualitative testing of mutagenicity of psychotropic drugs using the Salmonella-microsome system].
    Jiang SD
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1983 Apr; 16(2):95-8. PubMed ID: 6617370
    [No Abstract]   [Full Text] [Related]  

  • 5. Synthesis and mutagenicity of 1-nitropyrene 4,5-oxide and 1-nitropyrene 9,10-oxide, microsomal metabolites of 1-nitropyrene.
    Fifer EK; Howard PC; Heflich RH; Beland FA
    Mutagenesis; 1986 Nov; 1(6):433-8. PubMed ID: 3331683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial and mammalian mutagenicity tests: validation and comparative studies on 180 chemicals.
    Bartsch H; Malaveille C; Camus AM; Martel-Planche G; Brun G; Hautefeuille A; Sabadie N; Barbin A; Kuroki T; Drevon C; Piccoli C; Montesano R
    IARC Sci Publ; 1980; (27):179-241. PubMed ID: 7002778
    [No Abstract]   [Full Text] [Related]  

  • 7. Modeling the Ames Salmonella/microsome assay.
    Krewski D; Leroux BG; Bleuer SR; Broekhoven LH
    Biometrics; 1993 Jun; 49(2):499-510. PubMed ID: 8369384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of the correlation of bacterial mutagenicity with carcinogenicity of benzo(a)pyrene and four of its major metabolites by activation with intact liver cells instead of cell homogenate.
    Glatt HR; Billings R; Platt KL; Oesch F
    Cancer Res; 1981 Jan; 41(1):270-7. PubMed ID: 7448766
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of age on the ability of rat liver tissues to transform chemical promutagens to mutagens.
    Hilali A; Crutzen-Fayt MC; Gerber GB; Léonard A
    Gerontology; 1993; 39(3):125-7. PubMed ID: 8406054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of short-term tests for mutagenicity: on the optimal pH for the liver microsomal assay.
    Paolini M; Sapigni E; Hrelia P; Grilli S; Lattanzi G; Cantelli-Forti G
    Carcinogenesis; 1988 Dec; 9(12):2265-70. PubMed ID: 3191571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In vivo and in vitro studies of mutagenic properties of carcinogenic N-nitramines].
    Khudoleĭ VV; Malaveille C; Bartsch H
    Vopr Onkol; 1981; 27(11):59-62. PubMed ID: 7039103
    [No Abstract]   [Full Text] [Related]  

  • 12. Potent mutagenicity to Salmonella of an equimolar mixture of 52 chemicals used in five collaborative studies.
    Ashby J; Paton D; Callander RD
    Mutagenesis; 1988 Jul; 3(4):345-7. PubMed ID: 3062324
    [No Abstract]   [Full Text] [Related]  

  • 13. The use of in vivo-like concentrations of chemicals for validation of in vitro short-term genotoxicity assays--an in vivo equivalent dose concept.
    Dashwood RH; Combes RD
    Mutagenesis; 1987 Jul; 2(4):249-51. PubMed ID: 3325753
    [No Abstract]   [Full Text] [Related]  

  • 14. A study of the genotoxic potential of flavonoids using short-term bacterial assays.
    Czeczot H; Kusztelak J
    Acta Biochim Pol; 1993; 40(4):549-54. PubMed ID: 8140830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salmonella mutagenicity tests: II. Results from the testing of 270 chemicals.
    Mortelmans K; Haworth S; Lawlor T; Speck W; Tainer B; Zeiger E
    Environ Mutagen; 1986; 8 Suppl 7():1-119. PubMed ID: 3516675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indirect mutagen assay in human lymphocyte in the presence of a metabolic activation system.
    Pohlová H; Rössner P
    J Hyg Epidemiol Microbiol Immunol; 1986; 30(4):371-6. PubMed ID: 3805710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human cell mutagenicity of polycyclic aromatic hydrocarbon components of diesel emissions.
    Barfknecht TR; Hites RA; Cavaliers EL; Thilly WG
    Dev Toxicol Environ Sci; 1982; 10():277-94. PubMed ID: 6176427
    [No Abstract]   [Full Text] [Related]  

  • 18. Caffeine inhibits hepatic-microsomal activation of some dietary genotoxins.
    Alldrick AJ; Rowland IR
    Mutagenesis; 1988 Sep; 3(5):423-7. PubMed ID: 3070277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure of a base in DNA modified by Glu-P-1.
    Hashimoto Y; Shudo K; Okamoto T
    Chem Pharm Bull (Tokyo); 1979 Oct; 27(10):2532-4. PubMed ID: 527139
    [No Abstract]   [Full Text] [Related]  

  • 20. Sulfation in the metabolism and mutagenicity of N-hydroxy-2-fluorenylacetamide.
    Hinson JA; Andrews LS; Gillette JR
    Natl Cancer Inst Monogr; 1981 Dec; (58):113-6. PubMed ID: 6176868
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.